Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Biologics Are Coming, Commissioner McClellan Tells MBC

Executive Summary

Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council

You may also be interested in...



FDA Will Be Given Cost-Effectiveness Role, Acting Commissioner Predicts

Congress is likely to consider expanding FDA's mission to include direct consideration of economic factors in making approval decisions, Acting Commissioner Lester Crawford, PhD, predicted

FDA Will Be Given Cost-Effectiveness Role, Acting Commissioner Predicts

Congress is likely to consider expanding FDA's mission to include direct consideration of economic factors in making approval decisions, Acting Commissioner Lester Crawford, PhD, predicted

BIO Petition Opposes Generic Insulin, HGH; Asks FDA To Open Public Debate

The Biotechnology Industry Organization is asking FDA to initiate a public comment process on generic biologics before it moves forward in creating approval pathways for generic therapeutic proteins

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS041315

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel